Centene board chair James Dallas will step down from his role before the company’s 2023 stockholder meeting.
Mr. Dallas intends to stay on as a company director and run for that position again next year, according to an Aug. 1 news release.
“We are very grateful to James Dallas for guiding the Centene Board of Directors through a significant evolution of the company’s governance structure over the course of 2022,” CEO Sarah London said.
The Cigna Group has shuffled its executive lineup, appointing a new COO and a new CFO, while the CEO of…
Blue Shield of California CEO Lois Quam is stepping down after two months on the job.
Centene has appointed Kenneth Tanji to its board of directors, expanding the size of its board to 12.
Comments are closed.